Protagonist Therapeutics, Inc (PTGX) dividend history
PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$124.67−0.16 (-0.13%)
Close on Nov 17, 2026Market cap $8.07BP/E 121.0Yield –
Dividends
Protagonist Therapeutics has not reported a dividend
No dividend per share appears in Protagonist Therapeutics's annual filings since fiscal 2013.
See a number that looks wrong?